Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-21-008646

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Scopa James Paul Director 2021-04-26 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Loading xslF345X03/doc1.xml…